1. |
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27(5):1047-1053.
|
2. |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会.中国肥胖和2型糖尿病外科治疗指南(2014).中国实用外科杂志, 2014, 34(11):1005-1010.
|
3. |
Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France:the ECODIA survey. Diabetes Metab, 2000, 26(5):363-369.
|
4. |
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995, 222(3):339-352.
|
5. |
Wang TT, Hu SY, Gao HD, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type Ⅱ diabetes by increasing GLP-1. Ann Surg, 2008, 247(6):968-975.
|
6. |
Depaula AL, Macedo AL, Mota BR, et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc, 2009, 23(6):1313-1320.
|
7. |
田晓丰, 曹宏, 陈丹磊, 等.胃旁路术对非肥胖2型糖尿病大鼠降血糖作用机制的初步研究.中国实验诊断学, 2010, 14(6):833-835.
|
8. |
鲍兴, 都敏, 戴璟瑜, 等.胃旁路术对2型糖尿病大鼠的降糖作用及胰高血糖素样肽-1的影响.中华实验外科杂志, 2013, 30(1):36-38.
|
9. |
邹洪, 闫洪涛, 伍松, 等.回肠转位术对自发性糖尿病大鼠肝脏脂代谢的影响及其意义.第三军医大学学报, 2012, 34(11):1114-1116.
|
10. |
蔡逊, 叶家欣, 马丹丹, 等. RYGBP与BPD对2型糖尿病大鼠的血糖控制及GLP-1表达的影响.华南国防医学杂志, 2013, 27(8):540-543.
|
11. |
American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care, 2010, 33 Suppl 1:S11-S61.
|
12. |
Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery:an IDF statement for obese type 2 diabetes. Diabet Med, 2011, 28(6):628-642.
|
13. |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版).中国糖尿病杂志, 2011, 20(1):5.
|
14. |
邓治洲, 王烈, 林忆阳, 等.胃转流术对非肥胖型2型糖尿病的疗效观察及其对胰高血糖素样肽-1的影响.中国普外基础与临床杂志, 2009, 16(6):466-469.
|
15. |
Celik A, Ugale S, Ofluoglu H, et al. Metabolic outcomes of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) in obese type 2 diabetic patients. Obes Surg, 2015, 25(11):2018-2022.
|
16. |
Ersoz F, Duzkoylu Y, Deniz MM, et al. Laparoscopic Roux-en-Y gastric bypass with ileal transposition-an alternative surgical treatment for type 2 diabetes mellitus and gastroesophageal reflux. Wideochir Inne Tech Maloinwazyjne, 2015, 10(3):481-485.
|
17. |
Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg, 2005, 15(9):1258-1264.
|
18. |
许广松, 吴江, 秦春宏, 等.回肠转位术对GK大鼠血糖及GLP-1分泌影响的研究.中国糖尿病杂志, 2013, 21(11):1041-1045.
|
19. |
MacDonald PE, El-Kholy W, Riedel MJ, et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes, 2002, 51 Suppl 3:S434-S442.
|
20. |
陈博, 伍晓汀. 2型糖尿病手术干预机理及其研究进展.中国普外基础与临床杂志, 2012, 19(12):1283-1285.
|
21. |
Chelikani PK, Shah IH, Taqi E, et al. Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats. Obes Surg, 2010, 20(9):1281-1288.
|
22. |
Buchwald H, Dorman RB, Rasmus NF, et al. Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans:implications for ileal transposition. Surg Obes Relat Dis, 2014, 10(5):780-786.
|
23. |
Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis:role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg, 2005, 15(5):692-699.
|
24. |
Zhang L, Wang Y, Wang J, et al. Protein kinase C pathway mediates the protective effects of glucagon-like peptide-1 on the apoptosis of islet β-cells. Mol Med Rep, 2015, 12(5):7589-7594.
|
25. |
Ritz P, Vaurs C, Barigou M, et al. Hypoglycaemia after gastric bypass:mechanisms and treatment. Diabetes Obes Metab, 2016, 18(3):217-223.
|